RML

No 3-2-2/A, 1st Floor,

Beside Kumar Theatre, Kachiguda,
Hyderabad, Telangana 500027
Email id : rubraltd@gmail.com
CIN : L33100TG1991PLC013266
Website: www.rubramed.com

February 4, 2016
To,
BSE Limited,
P.J. Towers, Dalal Street,
Mumbai 400 001
Scrip Code: 531099
Sub: Outcome of Board Meeting
Re:
Financial Results for the Quarter and nine months period ended December 31, 2015
Dear Sir(s),
With reference to the captioned subject, please find enclosed herewith, the Financial Results of
the Company for the Quarter and Nine Months Ended December 31, 2015 which was approved
by the Board of Directors in their meeting held today i.e. February 4, 2016
Also attach is Limited Review Report for the period ended on December 31, 2015 given by the
Statutory Auditor of the Company.
You are requested to take note of the same.
Thanking You,
Yours faithfully
For Rubra Medicaments Limited

MayureshTawde
Director
DIN 01999743

RUBRA MEDICAMENTS LIMITED

Part I

(Rupees in Lacs)
Statement of Standalone Unaudited Results for the Quarter and 9 months period ended 31/12/2015
3 months ended Preceeding 3 Corresponding 3 Year to date Year to date Previous year
Particulars

Sr.
No

2
a
b
c
d
e
f

3
4
5
6
7

months
ended

Income from operations

Net Sales/Income form Operations (Net of Excise Duty)
Other Operating Income
Total Income from Operations (Net)
Expenses
Cost of Materials Consumed
Purchases of Stock-in-trade
Changes in Inventories of fininshed goods, work-in-progress and
stock-in-trade
Employee Benefit Expense
Depreciation and amortisation expenses
Other Expenses (Any item exceeding 10% of the total expenses
relating to continuing operatons to be shown separately)
Total Expenses
Profit / (Loss) from operations before other income, finance
costs and exceptional items (1-2)
Other Income
Profit / (Loss) from Ordinary activities before finance costs
and exceptional items (3+4)
Finance Cost

Profit / (Loss) from Ordinary activities after finance costs but

before exceptional items (5+6)
8 Exceptional Items
9 Profit / (Loss) from Ordinary activities before tax (7+8)
10 Tax Expenses
11 Profit / (Loss) from Ordinary activities after tax (9+10)
12 Extraordinary Items (net of tax expense)
13 Net Profit / (Loss) for the period (11+12)
14 Share of Profit/(Loss) of associates
15 Minority Interest
16 Net Profit / (Loss) after taxes, minority interest and share of profit
/(loss) of associates (13+14+15)
17 Paid-up equity share capital (Face value of the Share is Rs.10/each)
18 Reserves excluding Revaluation Reserves as per balance sheet)
of previous accounting year
19.i Earnings Per Share (EPS) (before Extraordinary items) of Rs. 10/each (not to be annualized)
a) Basic
b) Diluted
19.ii Earnings Per Share (EPS) (after Extraordinary items) of Rs. 10/(not to be annualized)
a) Basic
b) Diluted

months ended in figures for

the previous year
current
period
ended

figures for
pervious
period
ended

Ended

31/12/2015

30/09/2015

31/12/2014

31/12/2015

31/12/2014

31/03/2015

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

6.47
0.00
6.47

6.12
0.00
6.12

0.00
0.00
0.00

12.59
0.00
12.59

0.00
0.00
0.00

0.00
0.00
0.00

0.00
5.08
0.00

0.00
2.06
0.00

0.00
0.00
0.00

0.00
7.14
0.00

0.00
0.00
0.00

0.00
0.00
0.00

0.45
0.00
0.69

0.45
0.00
3.44

0.00
0.00
1.61

0.90
0.00
4.13

0.00
0.00
5.54

0.42
0.00
7.06

6.22
0.25

5.95
0.17

1.61
-1.61

12.17
0.42

5.54
-5.54

7.48
-7.48

0.00
0.25

0.00
0.17

0.00
-1.61

0.00
0.42

0.00
-5.54

0.00
-7.48

0.00
0.25

0.00
0.17

0.00
-1.61

0.00
0.42

0.00
-5.54

0.00
-7.48

0.00
0.25
0.00
0.25
0.00
0.25
0.00
0.00
0.25

0.00
0.17
0.00
0.17
0.00
0.17
0.00
0.00
0.17

0.00
-1.61
0.00
-1.61
0.00
-1.61
0.00
0.00
-1.61

0.00
0.42
0.00
0.42
0.00
0.42
0.00
0.00
0.42

0.00
-5.54
0.00
-5.54
0.00
-5.54
0.00
0.00
-5.54

0.00
-7.48
0.00
-7.48
0.00
-7.48
0.00
0.00
-7.48

546.83

546.83

546.83

546.83

546.83

546.83
-507.75

0.00
0.00

0.00
0.00

-0.03
-0.03

0.01
0.01

-0.10
-0.10

-0.14
-0.14

0.00
0.00

0.00
0.00

-0.03
-0.03

0.01
0.01

-0.10
-0.10

-0.14
-0.14

Notes:
The above results have been reviewed by the Audit Committee and taken on Record by the Board of Directors at its meeting held today

The Segment-wise details are not applicable to the company as company has no segments.

The result is provisional and unaudited and subject to change, regrouping and restatement.

Date: February 4, 2016

Place: Mumbai

For Rubra Medicaments Limited

Managing Director

Prakash Modi & Associates

Chartered Accountants
A-305, Durian Estate, Goregaon Mulund Link Road, Goregaon (E), Mumbai 400063. T: 9324476022 E: mandpca@gmail.com W: www.capmassociates.com

Limited Review Report of the Auditors

To,
The Board of Directors
Rubra Medicaments Limited
Hyderabad
Sub: Limited Review Report
We have reviewed the accompanying
statement
of unaudited
financial
results of Rubra
Medicaments Limited for the period ended December 31,2015. This statement is the responsibility
of the Company's Managementand

has been approved by the Board of Directors. Our responsibility

is to issue a report on these financial statementsbased

We conducted

our review in accordance

on our review.

with the Standard on Review Engagement

(SRE) 2400,

Engagements to Review Financial Statements issued by the Institute of Chartered Accountants of

India. This standard requires that we plan and perform the review to obtain moderate assurance as
to whether the financial statements are free of material misstatement. A review is limited primarily
to inquiries of company personnel and analytical procedure
provides less assurance than an audit. We have not performed

applied to financial data and thus

an audit and accordingly, we do not

express an audit opinion.

Based on our review conducted as above, nothing has come to our attention that causes us to
believe that theaccompanying statement of unaudited financial results prepared in accordance with
applicable accounting standardsand other recognized accounting practices and policies has not
disclosed the information
required to be disclosed interms of Regulation 33 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 includingthe manner in which it is to be
disclosed, or that it contains any material misstatement.
For Prakash Modi & Associates
Chartered Accountants
FRN: 116900W

Prakash Modi
Partner
M No: 101463
Place: Mumbai
Dated: 4th February 2016

411/412 Indraprastha-II-C, Jitendra Road, Malad(tast), Mumbai - 400 097.